Anavex Life Sciences Corp (AVXL)

[Investor2014]

The most important part of article to note, imo.

“Modest Phase III trial expectations

Nevertheless, based on evidence from both assets’ open-label studies, trofinetide and ANAVEX2-73 will likely result in modest 20–30% RSBQ improvements in their respective trials, Percy said. But it is important to wait for placebo-controlled Phase III trial results before drawing conclusions, he adds.”